Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 20:13:04094.
doi: 10.7189/jogh.13.04094.

Association of unsweetened and sweetened tea consumption with the risk of new-onset chronic kidney disease: Findings from UK Biobank and Coronary Artery Risk Development in Young Adults (CARDIA) study

Association of unsweetened and sweetened tea consumption with the risk of new-onset chronic kidney disease: Findings from UK Biobank and Coronary Artery Risk Development in Young Adults (CARDIA) study

Mengyi Liu et al. J Glob Health. .

Abstract

Background: The association between tea consumption and chronic kidney disease (CKD) remained inconsistent. We aimed to evaluate the association of tea consumption with new-onset CKD and examine the effects of common additives (milk and sweeteners) and genetic variations in caffeine metabolism on the association.

Methods: 176 038 and 3104 participants free of CKD at baseline in the United Kingdom Biobank (UK Biobank) and Coronary Artery Risk Development in Young Adults (CARDIA) study were included, respectively. Dietary information was collected using 24-hour dietary recall questionnaires. The study outcome was new-onset CKD.

Results: In the UK Biobank, during a median follow-up of 12.13 years, 3535 (2.01%) participants developed CKD. Compared with tea non-consumers, the risk of new-onset CKD was significantly lower in unsweetened tea consumers (hazard ratio (HR) = 0.84, 95% confidence interval (CI) = 0.76-0.93), but not in sweetened tea consumers (HR = 0.96, 95% CI = 0.85-1.08), regardless of whether milk was added to tea. Accordingly, relative to tea non-consumers, the adjusted HRs (95% CIs) of new-onset CKD for participants who reported drinking unsweetened tea 1.5 or fewer, >1.5 to 2.5, >2.5 to 3.5, >3.5 to 4.5, and >4.5 drinks/d were HR = 0.86, 95% CI = 0.75-0.99; HR = 0.88, 95% CI = 0.78-1.00; HR = 0.83, 95% CI = 0.73-0.94; HR = 0.83, 95% CI = 0.72-0.95; and HR = 0.86, 95% CI = 0.75-0.99. Moreover, the association of unsweetened tea consumption with new-onset CKD was stronger among those with faster genetically predicted caffeine metabolism levels, although the interaction was insignificant (P-value interaction = 0.768). Consistently, in the CARDIA study, compared with tea non-consumers, a significantly lower risk of new-onset CKD was found in unsweetened tea consumers (HR = 0.80, 95% CI = 0.65-0.98) but not in sweetened tea consumers (HR = 0.97, 95% CI = 0.70-1.34).

Conclusions: Compared with tea non-consumers, consumption of unsweetened tea, but not sweetened tea, was significantly associated with a lower risk of new-onset CKD, regardless of whether milk was added.

PubMed Disclaimer

Conflict of interest statement

Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and disclose no relevant interests.

Figures

Figure 1
Figure 1
Dose-response association of total, unsweetened, and sweetened tea consumption and new-onset CKD. Panel A. Dose-response association of total tea consumption and new-onset CKD. Panel B. Dose-response association of unsweetened tea consumption and new-onset CKD. Panel C. Dose-response association of sweetened tea consumption and new-onset CKD. Results were adjusted for age, sex, ethnicities, educational attainment, smoking status, alcohol consumption, physical activity, total energy intake, coffee consumption, body mass index, systolic blood pressure, diastolic blood pressure, glucose, triglycerides, total cholesterol, high-density lipoprotein cholesterol, estimated glomerular filtration rate and urine albumin-to-creatinine ratio. CKD – chronic kidney disease, HR – hazard ratio
Figure 2
Figure 2
Association of tea consumption and new-onset CKD stratified by tertiles of the wCMSG4 levels. Panel A. Association of unsweetened tea consumption and new-onset CKD stratified by tertiles of the wCMSG4 levels. Panel B. Association of sweetened tea consumption and new-onset CKD stratified by tertiles of the wCMSG4 levels. Results were adjusted for age, sex, ethnicities, educational attainment, smoking status, alcohol consumption, physical activity, total energy intake, coffee consumption, body mass index, systolic blood pressure, diastolic blood pressure, glucose, triglycerides, total cholesterol, high-density lipoprotein cholesterol, estimated glomerular filtration rate and urine albumin-to-creatinine ratio. CKD – chronic kidney disease, HR – hazard ratio, wCMSG4 – weighted genetic caffeine metabolism scores

Similar articles

Cited by

References

    1. GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709-33. 10.1016/S0140-6736(20)30045-3 - DOI - PMC - PubMed
    1. Lees JS, Welsh CE, Celis-Morales CA, Mackay D, Lewsey J, Gray SR, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nat Med. 2019;25:1753-60. 10.1038/s41591-019-0627-8 - DOI - PMC - PubMed
    1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260-72. 10.1016/S0140-6736(13)60687-X - DOI - PubMed
    1. Drew L.The growth of tea. Nature. 2019;566:S2-4. 10.1038/d41586-019-00395-4 - DOI - PubMed
    1. Inoue-Choi M, Ramirez Y, Cornelis MC, Berrington de González A, Freedman ND, Loftfield E.Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank: A Prospective Cohort Study. Ann Intern Med. 2022;175:1201-11. 10.7326/M22-0041 - DOI - PMC - PubMed